- Home
- AACT vs IMTX Comparison
AACT vs IMTX Comparison
Compare AACT & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AACT
- IMTX
- Stock Information
- Founded
- AACT 2021
- IMTX N/A
- Country
- AACT United States
- IMTX Germany
- Employees
- AACT N/A
- IMTX N/A
- Industry
- AACT
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AACT
- IMTX Health Care
- Exchange
- AACT Nasdaq
- IMTX Nasdaq
- Market Cap
- AACT 697.5M
- IMTX 653.9M
- IPO Year
- AACT 2023
- IMTX N/A
- Fundamental
- Price
- AACT $11.41
- IMTX $6.48
- Analyst Decision
- AACT
- IMTX Strong Buy
- Analyst Count
- AACT 0
- IMTX 4
- Target Price
- AACT N/A
- IMTX $14.67
- AVG Volume (30 Days)
- AACT 331.5K
- IMTX 387.1K
- Earning Date
- AACT 01-01-0001
- IMTX 08-12-2025
- Dividend Yield
- AACT N/A
- IMTX N/A
- EPS Growth
- AACT N/A
- IMTX N/A
- EPS
- AACT 0.36
- IMTX N/A
- Revenue
- AACT N/A
- IMTX $155,801,989.00
- Revenue This Year
- AACT N/A
- IMTX N/A
- Revenue Next Year
- AACT N/A
- IMTX $1.92
- P/E Ratio
- AACT $31.55
- IMTX N/A
- Revenue Growth
- AACT N/A
- IMTX 93.56
- 52 Week Low
- AACT $10.73
- IMTX $3.30
- 52 Week High
- AACT $11.62
- IMTX $13.09
- Technical
- Relative Strength Index (RSI)
- AACT 55.02
- IMTX 60.48
- Support Level
- AACT $11.40
- IMTX $6.44
- Resistance Level
- AACT $11.45
- IMTX $6.80
- Average True Range (ATR)
- AACT 0.04
- IMTX 0.32
- MACD
- AACT 0.00
- IMTX 0.02
- Stochastic Oscillator
- AACT 50.00
- IMTX 70.72
About AACT Ares Acquisition Corporation II
Ares Acquisition Corp II is a blank check company.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.